chr11-9408594-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PP3_ModerateBS2
The NM_006391.3(IPO7):c.275G>A(p.Arg92Gln) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000048 in 1,457,322 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Consequence
NM_006391.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IPO7 | NM_006391.3 | c.275G>A | p.Arg92Gln | missense_variant | 3/25 | ENST00000379719.8 | NP_006382.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IPO7 | ENST00000379719.8 | c.275G>A | p.Arg92Gln | missense_variant | 3/25 | 1 | NM_006391.3 | ENSP00000369042.3 | ||
IPO7 | ENST00000527431.1 | c.89G>A | p.Arg30Gln | missense_variant | 2/4 | 4 | ENSP00000435235.1 | |||
IPO7 | ENST00000533233.1 | n.*121G>A | non_coding_transcript_exon_variant | 3/4 | 4 | ENSP00000433313.1 | ||||
IPO7 | ENST00000533233.1 | n.*121G>A | 3_prime_UTR_variant | 3/4 | 4 | ENSP00000433313.1 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000405 AC: 1AN: 247100Hom.: 0 AF XY: 0.00000748 AC XY: 1AN XY: 133660
GnomAD4 exome AF: 0.00000480 AC: 7AN: 1457322Hom.: 0 Cov.: 30 AF XY: 0.00000552 AC XY: 4AN XY: 725044
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 28, 2024 | The c.275G>A (p.R92Q) alteration is located in exon 3 (coding exon 3) of the IPO7 gene. This alteration results from a G to A substitution at nucleotide position 275, causing the arginine (R) at amino acid position 92 to be replaced by a glutamine (Q). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at